VulnerabilityAnalyzed

CVE-2024-35433

ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Incorrect Access Control.

HIGH 8.1EPSS 0.46%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.46%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

ZKTeco ZKBio CVSecurity 6.1.1 is vulnerable to Incorrect Access Control. An authenticated user, without the permissions of managing users, can create a new admin user.

CVSS 3.1: 8.1 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
EPSS: 0.46% probability · 39th percentile
CISA KEV: Not listed
Weakness: CWE-284
Affected: zkteco/zkbio cvsecurity
Source: cve@mitre.org

References

https://github.com/mrojz/ZKT-Bio-CVSecurity/blob/main/CVE-2024-35433.mdExploit
https://github.com/mrojz/ZKT-Bio-CVSecurity/blob/main/CVE-2024-35433.mdExploit

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.